MULTIPLE NOVEL PEPTIDE EPITOPES IN HCV GENOTYPE-3A IDENTIFIED USING TWO PARALLEL APPROACHES

MULTIPLE NOVEL PEPTIDE EPITOPES IN HCV GENOTYPE-3A IDENTIFIED USING TWO PARALLEL APPROACHES

Bibliographic Details
Main Authors:	Boehmer, A, Pfafferott, K, Humphreys, I, Lucas, M, Swadling, L, Lauer, G, Gaudieri, S, Klenerman, P, Barnes, E
Format:	Conference item
Published:	2011

Similar Items

Full-length sequence analysis of HCV genotype-3A reveals novel regions of hypervariability
by: Humphreys, I, et al.
Published: (2007)

Immune responses in acute and chronic HCV genotype 3a infection detected by two distinct techniques
by: von Delft, A, et al.
Published: (2011)

The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design.
by: von Delft, A, et al.
Published: (2015)

A pan-genotype HCV T cell vaccine, in a simian adenovirus vector, to target T cell epitopes conserved across multiple HCV genotypes
by: Donnison, T, et al.
Published: (2018)

IL28B GENETIC STATUS IN ASSOCIATION WITH HCV SPECIFIC T-CELL IMMUNITY
by: Bucci, C, et al.
Published: (2011)

Ever closer to a prophylactic vaccine for HCV.
by: Swadling, L, et al.
Published: (2013)

CTL epitope escape and reversion in acute HCV infection.
by: Timm, J, et al.
Published: (2004)

CD8 epitope escape and reversion in acute HCV infection.
by: Timm, J, et al.
Published: (2004)

Constrained pattern of viral evolution in acute and early HCV infection limits viral plasticity.
by: Pfafferott, K, et al.
Published: (2011)

The global distribution and prevalence of HCV genotypes
by: Messina, J, et al.
Published: (2014)

The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes
by: von Delft, A, et al.
Published: (2017)

Constrained pattern of viral evolution in acute and early HCV infection limits viral plasticity.
by: Katja Pfafferott, et al.
Published: (2011-02-01)

HCV genotype-3a T cell immunity: specificity, function and impact of therapy
by: Humphreys, IS, et al.
Published: (2012)

HCV genotype-3a T cell immunity: specificity, function and impact of therapy.
by: Humphreys, I, et al.
Published: (2012)

HCV genotype-3a T cell immunity: Specificity, function and impact of therapy
by: Humphreys, I, et al.
Published: (2012)

Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes.
by: Harcourt, G, et al.
Published: (2004)

Viral vectored hepatitis C virus vaccines generate pan-genotypic T cell responses to conserved subdominant epitopes
by: Donnison, T, et al.
Published: (2020)

Comprehensive analysis of the HCV-specific CD8+T cell response in individuals with chronic or resolved HCV infection.
by: Lauer, G, et al.
Published: (2001)

Cross-reactivity of hepatitis C virus specific vaccine-induced T cells at immunodominant epitopes.
by: Kelly, C, et al.
Published: (2015)

HCV immunology--death and the maiden T cell.
by: Willberg, C, et al.
Published: (2003)

Influence of HIV and HCV on T cell antigen presentation and challenges in the development of vaccines
by: Mina eJohn, et al.
Published: (2014-10-01)

Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection
by: Dorota Zarębska-Michaluk, et al.
Published: (2022-01-01)

Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes.
by: Nicasio Mancini, et al.
Published: (2009-12-01)

Maintenance of HCV-specific T-cell responses in antibody-deficient patients a decade after early therapy.
by: Semmo, N, et al.
Published: (2006)

CD8AA T CELLS: A NOVEL LINEAGE ENRICHED IN THE LIVER IN CHRONIC HCV
by: Walker, L, et al.
Published: (2010)

Performance of 6 HCV genotyping 9G test for HCV genotyping in clinical samples
by: Shrikant Dasharath Warkad, et al.
Published: (2018-07-01)

Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure.
by: Rauch, A, et al.
Published: (2009)

Determination of Mixed HCV Genotypes
by: İmre ALTUĞLU, et al.
Published: (2017-09-01)

Co-localisation of hepatitis C virus drug-resistant mutations and immune-driven adaptations for genotype 1 and 3: relevance to therapy outcome
by: Gaudieri, S, et al.
Published: (2008)

A highly immunogenic novel genetic vaccine against HCV
by: Del Sorbo, M, et al.
Published: (2012)

A THERAPEUTIC VACCINE FOR HCV BASED ON NOVEL, RARE, ADENOVIRAL VECTORS
by: Kelly, C, et al.
Published: (2011)

Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy.
by: Rohrbach, J, et al.
Published: (2010)

HCV Detection, Discrimination, and Genotyping Technologies
by: Shrikant Dashrath Warkad, et al.
Published: (2018-10-01)

Geographical distribution of HCV genotypes in Mexico
by: Juan Francisco Sánchez-Ávila;, et al.
Published: (2007-07-01)

Distribution of HCV genotypes and HCV RNA viral load in different regions of Mexico
by: Ricardo Jimenez-Mendez, et al.
Published: (2010-01-01)

Quantitative and qualitative changes in HCV-specific liver infiltrating T-cells parallel the progression of liver damage in chronic hepatitis C.
by: Mullerova, I, et al.
Published: (2001)

HCV-indeterminate blood donors or occult HCV infection? Reply
by: Semmo, N, et al.
Published: (2005)

T-cell responses during early therapy for HCV infection.
by: Lauer, G, et al.
Published: (2003)

Hepatitis C virus (HCV) sequence variation induces an HCV-specific T-cell phenotype analogous to spontaneous resolution
by: Kasprowicz, V, et al.
Published: (2011)

Hepatitis C virus (HCV) sequence variation induces an HCV-specific T-cell phenotype analogous to spontaneous resolution.
by: Kasprowicz, V, et al.
Published: (2010)